Beijing Beilu Pharmaceutical (300016) — Financial Flexibility Index
Beijing Beilu Pharmaceutical (300016) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of CN¥132.62 Million (operating CF CN¥74.66 Million minus capex CN¥57.96 Million) represents 0% of total liabilities (CN¥852.80 Million). Check Beijing Beilu Pharmaceutical (300016) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Beilu Pharmaceutical Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Beijing Beilu Pharmaceutical across 19 annual periods. For the full cash flow conversion analysis, see 300016 cash flow conversion.
Annual Financial Flexibility Index for Beijing Beilu Pharmaceutical (2006–2024)
Year-by-year free cash flow to debt coverage for Beijing Beilu Pharmaceutical. Explore 300016 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | CN¥264.41 Million | CN¥163.02 Million | CN¥1.15 Billion | ▲ +17.2% |
| 2023 | 0.20x | CN¥203.07 Million | CN¥58.46 Million | CN¥1.03 Billion | ▼ -23.9% |
| 2022 | 0.26x | CN¥230.60 Million | CN¥127.81 Million | CN¥892.27 Million | ▼ -17.6% |
| 2021 | 0.31x | CN¥256.48 Million | CN¥108.73 Million | CN¥818.22 Million | ▼ -14.0% |
| 2020 | 0.36x | CN¥348.10 Million | CN¥176.00 Million | CN¥955.50 Million | ▼ -67.1% |
| 2019 | 1.11x | CN¥191.80 Million | CN¥156.81 Million | CN¥173.31 Million | ▼ -60.1% |
| 2018 | 2.77x | CN¥229.81 Million | CN¥175.75 Million | CN¥82.93 Million | ▼ -0.7% |
| 2017 | 2.79x | CN¥199.92 Million | CN¥144.92 Million | CN¥71.65 Million | ▲ +26.1% |
| 2016 | 2.21x | CN¥120.37 Million | CN¥76.17 Million | CN¥54.40 Million | ▲ +73.1% |
| 2015 | 1.28x | CN¥150.09 Million | CN¥80.85 Million | CN¥117.39 Million | ▲ +261.6% |
| 2014 | 0.35x | CN¥85.09 Million | CN¥42.11 Million | CN¥240.67 Million | ▼ -71.9% |
| 2013 | 1.26x | CN¥76.85 Million | CN¥41.37 Million | CN¥61.16 Million | ▼ -13.2% |
| 2012 | 1.45x | CN¥86.32 Million | CN¥22.86 Million | CN¥59.64 Million | ▼ -38.1% |
| 2011 | 2.34x | CN¥77.60 Million | CN¥45.73 Million | CN¥33.19 Million | ▼ -80.4% |
| 2010 | 11.92x | CN¥89.29 Million | CN¥37.51 Million | CN¥7.49 Million | ▲ +232.0% |
| 2009 | 3.59x | CN¥63.23 Million | CN¥57.91 Million | CN¥17.60 Million | ▲ +2616.7% |
| 2008 | -0.14x | CN¥-3.78 Million | CN¥-4.76 Million | CN¥26.52 Million | ▼ -158.6% |
| 2007 | 0.24x | CN¥12.50 Million | CN¥12.28 Million | CN¥51.36 Million | ▼ -37.7% |
| 2006 | 0.39x | CN¥21.15 Million | CN¥19.65 Million | CN¥54.10 Million | — |